Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
NCT00300222
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
400
Enrollment
INDUSTRY
Sponsor class
Conditions
Peripheral Nervous System Diseases
Pain
Neuralgia
Herpes Zoster
Shingles
Interventions
DRUG:
NGX-4010
Sponsor
NeurogesX